Restoring Breath: Biologic Innovation for the Most Vulenerable Patients

from Rx for Biotech · host Podcast Host Chris Leidli

Airway Therapeutics is taking on one of the toughest challenges in medicine - helping premature infants breathe on their own. In this episode of Rx for Biotech, CEO Marc Salzberg shares how zelpultide alfa, an investigational, first-in-class biologic, could transform care for newborns with bronchopulmonary dysplasia (BPD) and unlock a new future for respiratory medicine.

Episode metadata supplied by the publisher feed · Published Oct 28, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Restoring Breath: Biologic Innovation for the Most Vulenerable Patients

0:00 21:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 21 minutes long.

When was this Rx for Biotech episode published?

This episode was published on October 28, 2025.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!